Nautilus Biotechnology, Inc. (NAUT) - Quarterly Income Statement

Home
NAUT
Financials

0.6886 (USD) • At close April 30, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4
Revenue Numbers are in millions	0	0	0	0	0	8.212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	1.612	1.597	1.591	1.59	1.515	1.42	1.171	0.921	0	0.829	0.806	0.263	0.277	0.3	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	-1.612	-1.597	-1.591	6.622	-1.515	-1.42	-1.171	-0.921	0	-0.829	-0.806	-0.263	-0.277	-0.3	0	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0.806	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	9.911	12.823	12.288	12.436	12.93	12.466	11.996	11.912	10.877	9.587	9.571	8.856	9.658	9.893	8.244	6.38	4.835	3.894	3.317	2.751	2.47	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	7.308	7.157	6.812	8.353	8.677	7.535	7.079	7.104	7.183	6.717	6.249	6.616	6.364	6.923	6.324	4.317	3.582	1.426	0.71	0.649	4.127	0.355	0.178	0.088	0.154	111.684
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-3.6	0	0	0	0	0
SG&A Numbers are in millions	7.308	7.157	6.812	8.353	8.677	7.535	7.079	7.104	7.183	6.717	6.249	6.616	6.364	6.923	6.324	4.317	3.582	1.426	0.71	0.649	0.527	0.355	0.178	0.088	0.154	111.684
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	18.844	19.98	19.1	20.789	21.607	20.001	19.075	19.016	18.06	16.304	15.82	15.472	16.022	16.816	14.568	10.697	8.417	5.32	4.027	3.4	4.127	0.355	0.178	0.088	0.154	111.684
Operating Income Numbers are in millions	-18.844	-19.98	-19.1	-20.789	-21.607	-20.001	-19.075	-19.016	-18.06	-16.304	-15.82	-15.472	-16.022	-16.816	-14.568	-10.697	-8.417	-5.32	-4.027	-3.4	-2.997	-0.355	-0.178	-0.088	-0.154	-111.684
Operating Income Ratio Numbers are in millions	0	0	0	0	0	-2.436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	2.231	2.386	2.654	2.779	2.877	2.977	3.197	3.208	3.095	2.895	1.757	0.783	0.259	0.127	0.064	-0.016	0.008	-0.032	0.049	0.045	-0.273	0.741	0.795	0.945	0.872	738.284
Income Before Tax Numbers are in millions	-16.613	-17.594	-16.446	-18.01	-18.73	-17.024	-15.878	-15.808	-14.965	-13.409	-14.063	-14.689	-15.763	-16.689	-14.504	-10.713	-8.409	-5.352	-3.978	-3.355	-3.27	0.385	0.617	0.857	0.719	626.6
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	-2.073	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.336	0.694	0.75	0.904	0.832	0
Net Income Numbers are in millions	-16.613	-17.594	-16.446	-18.01	-18.73	-17.024	-15.878	-15.808	-14.965	-13.409	-14.063	-14.689	-15.763	-16.689	-14.504	-10.713	-8.409	-5.352	-3.978	-3.355	-3.27	0.385	0.617	0.857	0.719	626.6
Net Income Ratio Numbers are in millions	0	0	0	0	0	-2.073	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.13	-0.14	-0.13	-0.14	-0.15	-0.14	-0.13	-0.13	-0.12	-0.11	-0.11	-0.12	-0.13	-0.13	-0.12	-0.19	-0.25	-0.17	-0.13	-0.12	-0.4	0.054	0.086	0.12	0.1	87.18
EPS Diluted Numbers are in millions	-0.13	-0.14	-0.13	-0.14	-0.15	-0.14	-0.13	-0.13	-0.12	-0.11	-0.11	-0.12	-0.13	-0.13	-0.12	-0.19	-0.25	-0.17	-0.13	-0.12	-0.4	0.054	0.086	0.12	0.1	87.18
EBITDA Numbers are in millions	-14.988	-18.427	-18.585	-20.277	-21.091	-18.411	-18.607	-18.575	-16.889	-15.383	-14.96	-14.643	-14.957	-16.553	-14.291	-10.413	-8.203	-5.126	-3.838	-3.231	-2.839	0.385	0.617	0.857	0.719	626.6
EBITDA Ratio Numbers are in millions	0	0	0	0	0	-2.242	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Nautilus Biotechnology, Inc.

NASDAQ:NAUT Add to watchlist

NASDAQ:NAUT